Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial. [No authors listed] A Hartemann, G Bensimon, CA Payan… - The lancet Diabetes & …, 2013 - Elsevier GSID: 94oV8t50u7kJ
Type 1 diabetes. Atkinson MA, Michels AW. MA Atkinson, GS Eisenbarth, AW Michels - The Lancet, 2014 - Elsevier GSID: Vjt4OUHJ3PQJ
Treating human autoimmunity: current practice and future prospects. Gratz IK. MD Rosenblum, IK Gratz, JS Paw… - Science translational …, 2012 - science.org GSID: GpxiIH-E93YJ
